# PAR(2) Decisive Validation Tests

**Generated:** 2026-01-04

---

## Test 1: Per-Dataset Null Distributions

For each dataset, we shuffled the time order 100 times and recomputed Fibonacci%.

| Dataset | Timepoints | Observed Fib% | Null Fib% (95% CI) | z-score | Significant? |
|---------|------------|---------------|-------------------|---------|-------------|
| GSE157357_APC-Mut_BMAL-WT.csv | 22 | 29.3% | 24.0% (21.3-26.3) | 4.04 | Yes |
| GSE157357_APC-WT_BMAL-WT.csv | 22 | 26.0% | 24.7% (22.3-27.1) | 1.02 | No |
| GSE157357_Organoid_ApcKO-BmalKO_cir | 22 | 24.0% | 25.4% (23.6-27.1) | -1.50 | No |
| GSE157357_Organoid_ApcKO-WT_circadi | 22 | 33.4% | 28.5% (26.1-30.6) | 4.41 | Yes |
| GSE157357_Organoid_WT-BmalKO_circad | 22 | 30.9% | 29.0% (27.0-31.0) | 1.85 | No |
| GSE157357_Organoid_WT-WT_circadian. | 22 | 28.2% | 28.9% (26.7-31.1) | -0.56 | No |
| GSE17739_Kidney_CCD.csv | 6 | 25.4% | 25.5% (23.4-27.3) | -0.18 | No |
| GSE17739_Kidney_DCT.csv | 6 | 24.3% | 26.0% (23.9-27.9) | -1.68 | No |
| GSE201207_Young_Kidney_Aging.csv | 12 | 36.2% | 35.0% (32.8-37.0) | 0.98 | No |
| GSE221103_Neuroblastoma_MYC_OFF.csv | 14 | 33.2% | 31.7% (28.8-34.4) | 1.07 | No |
| GSE221103_Neuroblastoma_MYC_ON.csv | 14 | 28.1% | 32.2% (29.7-34.7) | -3.13 | No |
| GSE261698_APP_Bulk.csv | 24 | 26.6% | 27.9% (26.3-29.7) | -1.38 | No |
| GSE261698_WT_Bulk.csv | 23 | 51.0% | 28.7% (26.9-30.7) | 23.09 | Yes |
| GSE54650_Adrenal_circadian.csv | 24 | 23.3% | 24.8% (22.6-27.0) | -1.51 | No |
| GSE54650_Aorta_circadian.csv | 24 | 26.0% | 25.8% (24.3-27.5) | 0.22 | No |

**Summary:** 3/15 datasets show Fibonacci% significantly above null (p<0.05)

---

## Test 2: Downsample Control

24-timepoint dataset downsampled to simulate shorter sampling:

| Timepoints | Fib% | Explosive% |
|------------|------|------------|
| 6 | 23.1% | 22.02% |
| 8 | 29.6% | 12.07% |
| 10 | 28.9% | 9.65% |
| 12 | 37.3% | 0.17% |
| 14 | 37.5% | 0.06% |
| 18 | 31.4% | 0.13% |
| 24 | 23.0% | 0.01% |

**Conclusion:** Explosive% increases dramatically with fewer timepoints, confirming estimation artifact.

---

## Test 3: Period Distribution

Period distribution from complex-root genes (n=170055):

| Period Range | Percentage |
|--------------|------------|
| <12h (ultradian) | 46.7% |
| 12-20h | 40.4% |
| **20-28h (circadian)** | **9.9%** |
| 28-36h | 1.6% |
| >36h (infradian) | 1.5% |

---

## Test 4: Clock Gene Enrichment

Enrichment of known clock genes in the Fibonacci band vs background:

| Dataset | Enrichment Ratio |
|---------|------------------|
| GSE17739_Kidney_CCD.csv | 0.40x |
| GSE17739_Kidney_DCT.csv | 0.20x |
| GSE201207_Young_Kidney_Aging.csv | 0.30x |
| GSE221103_Neuroblastoma_MYC_OFF.csv | 1.01x |
| GSE221103_Neuroblastoma_MYC_ON.csv | 0.90x |
| GSE54650_Adrenal_circadian.csv | 1.83x |
| GSE54650_Aorta_circadian.csv | 1.04x |

---

## Test 5: Estimator Robustness

Comparing OLS AR(2) vs Yule-Walker estimation:

| Dataset | OLS Explosive% | YW Explosive% | Correlation |
|---------|----------------|---------------|-------------|
| GSE54650_Liver_circadian.csv | 0.00% | 0.00% | 0.982 |
| GSE17739_Kidney_CCD.csv | 12.32% | 0.00% | 0.493 |

**Conclusion:** If YW explosive% is much lower than OLS, the explosive signal is estimation noise.

---

*Report generated by PAR(2) Discovery Engine - Decisive Tests*
